通过关键受体和连接体相互作用了解瓦雷尼克林的功能
Sheenagh G Aiken1, Daniele Fiorito1, Matthew Harper1
1School of Chemistry, University of Bristol, Bristol BS8 1TS, UK.
概括
戒烟药物瓦伦尼克林在α4β2尼古丁乙胆受体 (nAChR) 上具有独特的相互作用. 像β2S133这样的关键残留物对其功能至关重要,揭示了其独特的作用机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 瓦伦尼克林于2006年获得批准,是第一类基于尼古丁的戒烟疗法.
- 它向α4β2尼古丁性乙胆受体 (nAChR),但其精确的分子相互作用仍然不清楚.
- 了解这些相互作用是解释其临床疗效的关键,并将其与尼古丁和细胞因素等相关化合物区分开来.
研究的目的:
- 阐明瓦雷尼克林在α4β2 nAChR的特定分子相互作用.
- 为了确定关键的氨基酸残留物和结构特征,负责瓦伦尼克林独特的药理学特征.
- 为了深入了解瓦伦尼克林在戒烟中的作用机制.
主要方法:
- 多学科的方法结合了分子和功能测试.
- 位点定向突变发生,以探测特定结合位点残留物的作用 (例如,α4T139,α4T183,β2S133).
- 对瓦伦尼克林新型变异的分析,以评估结构小组 (如诺林组) 的重要性.
主要成果:
- 确定了特定的结合点残留物 (α4T139,α4T183,β2S133) 作为瓦伦尼克林功能的关键调节剂.
- 证明用氨酸替代β2S133显著降低了瓦伦尼克林的疗效,突出了它的关键作用.
- 发现昆素部分的定位对于瓦雷尼克林介导的受体激活至关重要.
结论:
- 瓦伦尼克林在α4β2 nAChR表现出独特的相互作用网络,使其与尼古丁和细胞因素区别开来.
- 特定的残留物,特别是β2S133,以及昆素部分的位置是瓦伦尼克林疗效的关键决定因素.
- 这些发现为放弃吸烟的瓦伦尼克林的作用机制提供了更深入的分子理解.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Cholinergic Receptors: Nicotinic
5.2K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.2K


